Annual report pursuant to Section 13 and 15(d)

Segments - Operating Segments (Details)

v3.8.0.1
Segments - Operating Segments (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Segment Reporting Information [Line Items]                      
Revenue from services                 $ 889,076 $ 1,012,129 $ 329,739
Revenue from products                 107,759 83,467 80,146
Revenue from transfer of intellectual property and other                 70,668 126,065 81,853
Operating loss                 (280,062) (73,275) (98,481)
Depreciation and amortization                 102,093 96,576 42,248
Income (loss) from investment in investees                 (14,471) (7,652) (7,105)
Revenues $ 193,699 $ 263,495 $ 314,213 $ 296,096 $ 275,489 $ 298,035 $ 357,100 $ 291,037 1,067,503 1,221,661 491,738
Assets 2,584,556       2,766,619       2,584,556 2,766,619  
Goodwill 717,099       704,603       717,099 704,603 743,348
United States                      
Segment Reporting Information [Line Items]                      
Revenues                 908,971 1,014,389 344,464
Ireland                      
Segment Reporting Information [Line Items]                      
Revenues                 77,285 137,785 78,989
Chile                      
Segment Reporting Information [Line Items]                      
Revenues                 44,286 35,364 29,885
Spain                      
Segment Reporting Information [Line Items]                      
Revenues                 18,285 15,812 16,622
Israel                      
Segment Reporting Information [Line Items]                      
Revenues                 13,951 15,317 18,107
Mexico                      
Segment Reporting Information [Line Items]                      
Revenues                 4,605 2,988 3,671
Other                      
Segment Reporting Information [Line Items]                      
Revenues                 120 6 0
Corporate, Non-Segment                      
Segment Reporting Information [Line Items]                      
Revenue from services                 0 0 140
Revenue from transfer of intellectual property and other                 0 0 0
Operating loss                 (55,615) (60,041) (46,512)
Depreciation and amortization                 138 89 85
Income (loss) from investment in investees                 0 0 0
Assets 60,604       63,181       60,604 63,181  
Goodwill 0       0       0 0  
Segment Reconciling Items                      
Segment Reporting Information [Line Items]                      
Operating loss                 0 0 (1,280)
Pharmaceutical | Operating Segments                      
Segment Reporting Information [Line Items]                      
Revenue from services                 0 0 0
Revenue from products                 107,759 83,467 80,146
Revenue from transfer of intellectual property and other                 70,668 126,065 81,853
Operating loss                 (87,907) (9,841) (40,395)
Depreciation and amortization                 27,513 18,254 10,245
Income (loss) from investment in investees                 (12,646) (7,665) (7,105)
Assets 1,282,564       1,294,916       1,282,564 1,294,916  
Goodwill 264,313       251,817       264,313 251,817  
Diagnostics | Operating Segments                      
Segment Reporting Information [Line Items]                      
Revenue from services                 889,076 1,012,129 329,599
Revenue from transfer of intellectual property and other                 0 0 0
Operating loss                 (136,540) (3,393) (10,294)
Depreciation and amortization                 74,442 78,233 31,918
Income (loss) from investment in investees                 (1,825) 13 $ 0
Assets 1,241,388       1,408,522       1,241,388 1,408,522  
Goodwill $ 452,786       $ 452,786       $ 452,786 $ 452,786